Emma studied biochemistry at Imperial College London then stayed on for a Masters and PhD on her favourite topic, immunology. After almost a decade there, she braved the move out of London (a whole 12 miles south) and joined The Institute of Cancer Research to study multiple myeloma, a white blood cell cancer. She left the lab for the final time in 2010 and, after a couple of years at Breakthrough Breast Cancer, joined the Science Communications team at Cancer Research UK.
Category: Science blog January 8, 2015
In the second installment of our series on the HOPON clinical trial we hear from the research nurses who help to run the trial in Liverpool.
Category: Science blog January 7, 2015
In the first of a three-part series we hear from a doctor whose clinical trial was funded by Stand Up To Cancer in 2012.
Category: Science blog December 17, 2014
In the second part of this two-part series, we look at our work with industry, why it’s important, and how we try to influence the way drugs get to patients.
Category: Science blog December 16, 2014
In this first in a two-part series, we take a look at how cancer drugs get to patients, and at some of reasons behind the spiralling costs.